Introduction
8 1
Peptides enrichment and fractionation
scanned to control homogeneity of sample loading. Immunodetection was 1 performed as follows. Membranes were blocked in phosphate buffer saline 2 (PBS), 0.05% Tween 20, 5% nonfat milk for 1 hour at room temperature and 3 incubated with primary antibody overnight at 4°C. Primary antibodies were used 4 at the following dilutions in blocking buffer: 1:1000 for rabbit polyclonal anti-alpha 5 1 inhibitor 3 (ab61338, Abcam, Cambridge, UK), 1:10'000 for rabbit monoclonal 6
anti-alpha-tubulin (ab52866, Abcam), 1:500 for mouse monoclonal anti-beta-7 tubulin (sc-53140, Santa-Cruz Biotechnology, Santa Cruz, CA, USA), 1:500 for 8 goat polyclonal anti-coatomer gamma (sc-14167, Santa-Cruz Biotechnology). 9
Membranes were washed with blocking buffer and incubated with secondary 10 antibody (Dako, Glostrup, Denmark) at 1:2'000 in blocking buffer for 1 hour at 11 room temperature. Membranes were washed in PBS, 0.05% Tween 20, 12 developed with BM Chemiluminescence Blotting Substrate (Roche, Basel, 13 Switzerland), and visualized on X-ray films. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 3. Results 
Induction of acute pancreatitis 2
Induction of experimental acute pancreatitis was assessed by measuring serum 3 amylase and lipase activities 5 hours after the second caerulein injection. As 4 shown in Figure 1 , these two markers of pancreatic damage were strongly 5 increased in pancreatitis rats compared to healthy controls. 6 7
Peptides identification 8
Combination of centrifugal ultrafiltration, OFFGEL electrophoresis (OGE) 9 fractionation and LC-MS/MS analysis allowed to identify 1216 unique peptides 10 corresponding to 282 proteins in control sample 1 (Supplementary Table 6 ). The efficiency of OGE peptide fractionation 18 was evaluated by calculating the number of peptides identified in each fraction. 19
The pH of each fraction was also measured to check that the pH gradient was 20 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 [28, 29] . These data also confirmed that the pH gradient was correctly 1 established all along the IPG strip during IEF. As previously indicated, MS data 2 were searched against UniProt_Swiss-Prot database without specifying any 3 proteolytic enzyme in order to maximize the number of identified peptides, 4 irrespective of the mechanism by which they were obtained. MS data were also 5 search against UniProt_Swiss-Prot database with trypsin specified as the 6 proteolytic enzyme (data not shown). Only a few peptides were identified, 7
indicating that almost all peptides detected in pancreatic extracts were not tryptic 8 peptides. Examples of spectra obtained for peptides identified from 9 carboxypeptidase B and murinoglobulin 1 are presented in Figure 3 . 10 11
Biological processes 12
For further analysis of peptide identification results, we made a selection from the 13 total list of identifications. We excluded peptides from proteins identified in a only 14 one pancreatic extract, peptides from proteins identified in a several samples but 15 with only a single peptide, and peptides from proteins identified in two samples 16 with only two and one unique peptides, respectively. The goal was to focus on 17 peptides from proteins identified with a high level of confidence. The 487 proteins 18 matching these criteria are listed in Supplementary Table 7 . Each of these 19 proteins was attributed a biological function using data from Swiss-Prot and Gene 20
Ontology databases. The number of peptides associated to each functional 21 category was calculated for the pancreatitis and the control samples. The 22 functional classification of these peptides is presented in Figure 4 . The most 23 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 represented functional categories in control samples were cytoskeleton, 1 translation, metabolic processes and unknown. These observations were 2 consistent between samples with coefficients of variation (CV) of 21% for 3 cytoskeleton, 21% for metabolic processes, 23% for translation, and 5.9% for 4 unknown. Cytoskeleton, metabolic processes, and translation represent nearly 5 50% of the identified peptides in control samples, which is not surprising when 6 considering cellular abundance of the corresponding proteins. In pancreatitis 7 samples, cytoskeleton and translation were the only two functional categories 8 above 10%, with cytoskeleton representing more than one fourth of the 9
identifications. The proportion of peptides from metabolic process and unknown 10 were decreased to 9.1% and 7.8%, respectively. As observed for controls, inter-11 samples reproducibility was quite good with CVs of 4.7% for cytoskeleton, 48% 12 for metabolic processes, 11% for translation, and 28% for unknown. The two 13 main differences between the two groups of samples were peptides from 14 cytoskeletal proteins, which changed from 19.3% in controls to 27.6% in 15 pancreatitis samples and peptides from proteins involved in inflammatory 16 response, which changed from 0.7% in controls to 7.8% in pancreatitis samples. At the level of individual proteins, an important variability in the number of 1 identified peptides was often observed between samples from the same group. 2 Furthermore, an overlap was often found between control and acute pancreatitis 3 groups (Supplementary Table 7 ). Normalizing these data to the total number of 4 peptides identified in the pancreatic extract decreased inter-samples variability 5 for some proteins but, in numerous cases, did not change the situation. In this 6 context, the question was to know whether peptidomic results could be indicative 7 of the concentration of a native protein or of its degradation status in pancreatic 8 extracts. We therefore compared, for selected proteins, immunoblot data with 9 peptidomic results, using both the absolute and relative numbers of identified 10 peptides. We first considered alpha and beta tubulin chains, which have been 11 detected with a large number of unique peptides in both control and pancreatitis 12 samples. For tubulin alpha chains, the mean number of identified peptides and 13 the mean ratio, obtained by normalization to the total number of identified 14 peptides, were increased by approximately 2-fold in pancreatitis samples 15 compared to controls (Table 1) . There was an overlap between the control and 16 pancreatitis groups for the absolute numbers of identified peptides but not for the 17 ratios. Immunoblot performed for alpha tubulin showed a strong decrease in the 18 native protein concentration in pancreatitis extracts with faint bands of lower 19 molecular weight, probably corresponding to proteolytic products ( Figure 5) . 20
Degradation products were also detected in control samples. For tubulin beta 21 chains, the mean number of identified peptides and the mean normalized ratio 22
were slightly higher in pancreatitis samples compared to controls but there was 23 an overlap between the two groups for both parameters (Table 1) . Immunoblot 1 results indicated that the beta tubulin concentration was reduced in pancreatitis 2 samples compared to controls ( Figure 5 ). Band intensities suggested that it was, 3 however, to a lower extent than for alpha tubulin. Taken together, these data 4 suggest that the decrease in native protein concentration observed for alpha and 5 beta-tubulin chains in pancreatitis samples were associated with modifications of 6 their peptide pattern detected by peptidomic analysis. This correlation appeared 7 to be better when normalizing to the total number of identified peptides rather 8 than with absolute numbers of identified peptides. A comparison of peptidomic 9
and immunoblot data was also performed for coatomer gamma. Peptides from 10 this protein were identified in two controls and in two pancreatitis samples. The 11 inter-samples variability was high either considering the total number of identified 12 peptides or normalized ratios (Table 1 ). In contrast, homogenous results were 13 obtained by immunoblot for both control and pancreatitis groups. In controls, the 14 native protein was clearly visible along with faint bands of lower molecular weight 15 suggesting the presence of proteolytic products. In pancreatitis samples, the 16 native proteins was not or faintly visible with a strong pattern of degradation. In 17 the case of coatomer gamma, peptidomic data were therefore not reflecting 18 changes in the concentration and the degradation status of the native protein. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 all pancreatitis samples and the number of identified peptides was at least 2 1 times higher than in controls (Table 2 ). For half of them, no peptides were 2 detected in controls extracts. Most of these proteins were related to inflammatory 3 response. The list also includes inducible heat shock proteins (HSP) and 4 digestive proteases. Sequences analysis showed that for some of these proteins, 5 the peptides identified using peptidomics were located only or predominantly 6 within a specific region of the protein sequence. This suggests that proteolysis 7 could be related to a particular function of the protein. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 4. Discussion 1 We developed a peptidomic method for the analysis of the LMW proteome in rat 2 pancreatic tissue extracts. The objective was to set up an analytical tool that 3 allows monitoring proteolytic processes during the course of acute pancreatitis. In 4 order to evaluate the reliability of this peptidomic workflow, we performed a 5 qualitative analysis of peptide patterns in pancreatic extracts from rats with 6 experimental acute pancreatitis and healthy controls. As exemplified by peptide 7 sequences presented for murinoglobulin or carboxypeptidase B, analysis of MS 8 data showed that almost all identified peptides were not tryptic. This was 9
confirmed by the fact that database searching with trypsin selected as the 10 proteolytic enzyme yielded only a few identifications (data not shown). 11
Considering the multiple endo-and exoproteases present in the pancreas, these 12 data suggest that the peptides identified in this study resulted from various 13 proteolytic cleavages. 14 The results we obtained underlined the complexity of peptidomic analysis and 15 potential problems for results interpretation. Inter-samples variability was high in 16 both control and pancreatitis groups regarding the total number of peptides 17 identified. The fact that extracts were prepared from different amounts of tissue 18
could not fully explain this variability, in particular for control samples. In addition, 19 contrary to what one should expect, the number of unique peptides identified was 20 not higher in pancreatitis samples. These observations were also true, in many 21 cases, when peptides patterns detected for individual proteins were considered. 22
Different factors, probably acting in combination, can explain these results. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Firstly, biological variability between animals and differences in the response to 1 the experimental model can cause inter-samples variability. However, no direct 2 correlation between peptidomic results and serum amylase or lipase level was 3 found. Secondly, technical variability, for example during tissue extracts 4 preparation or OGE fractionation, can introduce some bias. Thirdly, a part of the 5 identified peptides may correspond to the so-called "degradome". Such peptides 6
are not related to biological or pathobiological processes but are produced post-7 mortem during tissue collection and sample processing. Pancreas was shown to 8 be a tissue that may produce a relatively high amount of such degradation 9 products when using a snap-freezing tissue sampling procedure [30] . A number 10 of peptides detected in controls and pancreatitis extracts may therefore 11 correspond to degradome products. Finally, the peptidomic method was not 12 quantitative and the number of peptide detected in pancreatitis extracts was not 13 reflecting absolute amounts present in the sample. Due the very high sensitivity 14 of the Orbitrap mass spectrometer, similar numbers of peptides could have been 15 detected in controls samples using data-dependent acquisition despite the fact 16 that peptide concentrations were much lower than in pancreatitis samples. This 17 could explain that results obtained for the different functional categories, as well 18 as for individual proteins such as tubulin alpha chains, appeared more consistent 19 between samples from the same group when normalizing to the total number of 20 identified peptides. Taken together, these data stress the need for developing 21 reliable normalization strategies for further comparative peptidomic studies using 22 quantitative approaches, such as label-free quantification. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Despite these limitations, a number of results obtained in this study were fully 1 relevant in the context of acute pancreatitis. Analysis of the relation between 2 identified peptides and biological processes showed that the proportion of 3 peptides from proteins associated to inflammation, a key pathobiological process 4 of acute pancreatitis, was strongly increased in pancreatitis samples. This 5 phenomenon can be explained by the fact that the concentration of inflammatory 6 proteins is increased in the pancreas following disease onset and, as a 7 consequence, the number of proteolytic peptides detected by MS for these 8 proteins was increased. Most of the inflammatory-related peptides detected in 9 acute pancreatitis samples were from plasma proteins, such as apolipoproteins 10 AI and AIV, alpha-1-inhibitor 3, murinoglobulin1, alpha-2-HS-glycoprotein, 11 complement C3, fibrinopeptides A and B, or serine protease inhibitor A3K, which 12 arose in pancreatic tissue due to plasma extravasation and edema [2]. Increased 13 pancreatic levels of apolipoprotein AI, alpha-1-inhibitor 3, murinoglobulin1 and 14 complement C3 have been previously described in caerulein-induced pancreatitis 15 using 2-DE and immunoblotting [22] . We also detected in pancreatitis samples, 16 but not in controls, peptides from proteins whose expression is induced in the 17 pancreas in response to pancreatic tissue injury and acute pancreatitis: clusterin 18 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and microfilaments are degraded in the early steps of acute pancreatitis, which 1 results in the disassembly of acinar cell cytoskeleton [39, 40] . This process is 2 believed to be responsible for the inhibition of digestive enzyme secretion by 3 Interestingly, analysis of peptidomic data obtained for some proteins provided 5 information on specific molecular mechanisms related to acute pancreatitis 6 pathobiology. The first examples were murinoglobulin 1 and alpha-1-inhibitor 3. 7
These proteins, highly homologous to human alpha-2-macroglobulin, are 8 protease inhibitors that function through a trapping mechanism. The target 9 protease cleaves the alpha-macroglobulin within a specific sequence called the 10 "bait region", thereby triggering a conformational change of the alpha-11 macroglobulin and entrapment of the endopeptidase [50] . In a previous study, we 12 showed using 2-DE, MS analysis and immunoblotting that high levels of amino-13 and carboxy-terminal fragments of alpha-1-inhibitor 3 and murinoglobulin 1, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 localized within the activation sequence, which is cleaved upon activation of the 1 zymogen. Again, peptidomic results were complementary to 2-DE analysis, which 2 allowed visualizing the raise of active carboxypeptidase B in pancreatic extracts 3 following caerulein treatment [22] . 4
This study demonstrated that peptidomic analysis of pancreatic tissue extracts is 5 an interesting approach for investigating pathobiological processes involved in 6 acute pancreatitis. Analysis of peptide patterns from pancreatitis and control 7 samples allowed highlighting a number of differences that were relevant to acute 8 pancreatitis pathobiology. In addition, proteolytic fragments from a few proteins 9 that have never been described in acute pancreatitis were detected in 10 pancreatitis samples but not in the healthy control, which suggests that analysis 11 of the LMW proteome could bring new insights in disease mechanisms. 12 Nevertheless, this study also underlined the complexity of peptidomic analysis 13 and identified a number of pitfalls that can lead to experimental bias. Therefore, 14 peptidomic analysis should be used in combination with proteomic techniques 15 and careful bibliographical and database searches should be done to help for 16 data interpretation. Combination of this peptidomic workflow with label-free 17 quantitative LC-MS/MS would probably be of great interest for the study of 18 experimental models of acute pancreatitis but performing reliable comparative 19 studies will require establishing suitable normalization procedures. Including rats 20 treated with protease-inhibitors in future peptidomic studies could also be of 21 interest to better understand the role of proteolytic processes in acute 22 pancreatitis pathobiology. 23 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Tables:   1   2   Table 1 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 searched against UniProt_Swiss-Prot database using Phenyx software 5 (GeneBio). Rattus norvegicus taxonomy was specified for database searching. 6
False positive peptide ratio for protein and peptide identifications was below 1%. 7
Exp. data: experimental data; b, y: b and y ions. 13 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21. Jaffray, C.; Yang, J.; Carter, G.; Mendez, C.; Norman J. Pancreatic elastase 1 activates pulmonary nuclear factor kappa B and inhibitory kappa B, 2 mimicking pancreatitis-associated adult respiratory distress syndrome. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure 2: Peptide fractionation using OFFGEL electrophoresis. Pancreatic peptides were enriched by centrifugal ultrafiltration using a 10kDa molecular weight cut-off. Peptides were fractionated according to their pI on an Agilent 3100 OFFGEL Fractionator using commercial 24 cm IPG pH 3-10 linear strips (GE Healthcare). Peptidic fractions were recovered in separate tubes and pH values were measured to check accuracy of the pH gradient. Peptide fractions were analyzed using a nanoRP-UPLC system (Waters) connected to an LTQ-Orbitrap mass spectrometer (Thermo Scientific). Peptides identification was carried out using Phenyx software (Genebio). The number of peptides identified and the pH measured after IEF are indicated for each OFFGEL fraction from pancreatic extract of pancreatitis sample 1. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure 3: MS spectra of peptides identified from carboxypeptidase B and murinoglobulin 1. MS analysis was performed on a LTQ Orbitrap XL (Thermo Scientific) as described in Material and Methods section. Peak lists were searched against UniProt_Swiss-Prot database using Phenyx software (GeneBio). Rattus norvegicus taxonomy was specified for database searching. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 Figure 4 : Biological functions associated to the peptides identified in control and pancreatitis samples. 487 proteins were selected from the total list of identifications by excluding peptides from proteins identified in a only one pancreatic extract, peptides from proteins identified in a several samples but with only a single peptide, and peptides from proteins identified in two samples with only two and one unique peptides, respectively (Supplementary Table 7) . A biological function was attributed to each of these proteins using data from Swiss-Prot and Gene Ontology databases. The number of peptides associated to each functional category was calculated for the pancreatitis and the control groups. Percentages corresponding to each functional category are presented as pie charts. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
